| Carmilia Jiménez Ramírez is the Head of Global Quality Control Analytical Technologies at BioMarin. Her team is tasked with life cycle management of analytical control systems from early clinical stages through commercialization for BioMarin’s product portfolio. Her team oversees authorship and developing strategies for analytical sections in regulatory submissions, design and execution of studies for process development, and technical support to manufacturing and QC for laboratory investigations. Additionally, her team is responsible for global stability programs, reference standard and critical reagent management for clinical and commercial products. She has held various scientific positions at Ajinomoto Bio Pharma Services, Gilead Sciences, Merck and Amgen within quality control and analytical development departments, focusing on management of biologics programs for oncology, hematology, rheumatology and renal disease indications. Carmilia serves as a member of the CASSS Board of Directors and as an active volunteer in multiple CASSS symposia and fora since 2014. She received a bachelor's degree in Biology and Pre-medical Sciences from the University of Puerto Rico, Mayagüez Campus, a doctorate degree in Microbiology and Immunology from Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, and has conducted research as a Postdoctoral Fellow at St. Jude Children's Research Hospital, Memphis, Tennessee. |
